RxDoctor Payments Data

Stephen Honeycutt, PA

Surgical · Slidell, LANPI 1275560849

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Stryker at 37.2% of the total. Reporting peaked in 2022 at $501 and has fallen 69.1% since, to $155 in 2025.

$1,165in general payments, 2019–2025

Across 22 payments — averaging $52.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$433
  • Edwards Lifesciences$172
  • Novo Nordisk$122
  • Actelion Pharmaceuticals US, Inc.$122
  • Gilead$113
  • Jazz Pharmaceuticals Inc.$85
  • plus $119 from 5 others

What the payments were for

  • Food & beverage$1,165100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,165 in reported general payments places this provider in the 65th percentile of 130 surgical providers in Louisiana.

See all surgical providers in Louisiana

Medicare billing

Part B allowed, 2024
$22,887
Medicare patients
147
Services billed
2,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen449$3,217
Celecoxib179$2,240
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen269$1,607
Gabapentin189$1,261
Diclofenac Sodium18$615
Diclofenac Potassium26$513
Meloxicam203$440
Ibuprofen51$400
Tramadol Hcl145$371
Pregabalin20$337
Ondansetron Hcl53$177
Methylprednisolone20$145
Naproxen12$89
Tizanidine Hcl13$83
Doxycycline Hyclate12$64

Paid to pharmacies, not to this prescriber.

Other surgical in Slidell

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →